HSP90AA1 and cancer: Due to Hsp90 being involved in signaling pathways promoting cancer cell progression, it has become an attractive and well-established therapeutic cancer target, with Hsp90 inhibitors being continually developed and reviewed in clinical trials in an ongoing basis [43].